Overview

Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery

Status:
Completed

Trial end date:
2012-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and efficacy of two doses of TB-402 administered as a single intravenous infusion for the prevention of VTE in subjects undergoing total hip replacement surgery.

Phase:

Phase 2

Details

Lead Sponsor:

ThromboGenics

Collaborator:

BioInvent International AB

Treatments:

Antibodies, Monoclonal
Rivaroxaban